BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23291088)

  • 1. Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease.
    Ndrepepa G; Braun S; King L; Fusaro M; Keta D; Cassese S; Tada T; Schömig A; Kastrati A
    Am J Cardiol; 2013 Mar; 111(6):804-10. PubMed ID: 23291088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease.
    Ndrepepa G; Braun S; Tada T; King L; Cassese S; Fusaro M; Keta D; Kastrati A; Schmidt R
    Indian J Med Res; 2014 Sep; 140(3):392-400. PubMed ID: 25366207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography.
    Cheng JM; Akkerhuis KM; Meilhac O; Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Piquer D; Merle D; du Paty E; Galéa P; Jaisser F; Rossignol P; Serruys PW; Boersma E; Fareh J; Kardys I
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1078-84. PubMed ID: 24651681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention.
    Ndrepepa G; Braun S; Cassese S; Fusaro M; King L; Kastrati A; Schmidt R
    Cardiovasc Revasc Med; 2013; 14(5):264-9. PubMed ID: 23969223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease.
    Ndrepepa G; Braun S; King L; Cassese S; Tada T; Fusaro M; Hadamitzky M; Haase HU; Schömig A; Kastrati A
    Clin Sci (Lond); 2013 Feb; 124(4):259-68. PubMed ID: 22974091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid and prognosis in angiography-proven coronary artery disease.
    Ndrepepa G; Braun S; King L; Fusaro M; Tada T; Cassese S; Hadamitzky M; Haase HU; Schömig A; Kastrati A
    Eur J Clin Invest; 2013 Mar; 43(3):256-66. PubMed ID: 23278454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of uric acid with mortality in patients with stable coronary artery disease.
    Ndrepepa G; Braun S; King L; Hadamitzky M; Haase HU; Birkmeier KA; Schömig A; Kastrati A
    Metabolism; 2012 Dec; 61(12):1780-6. PubMed ID: 22749121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study.
    Liu C; Zhang Y; Ding D; Li X; Yang Y; Li Q; Zheng Y; Wang D; Ling W
    Atherosclerosis; 2016 Jun; 249():116-24. PubMed ID: 27088866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
    Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease.
    Capodanno D; Di Salvo ME; Cincotta G; Miano M; Tamburino C; Tamburino C
    Circ Cardiovasc Interv; 2009 Aug; 2(4):302-8. PubMed ID: 20031732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
    von Haehling S; Papassotiriou J; Hartmann O; Doehner W; Stellos K; Geisler T; Wurster T; Schuster A; Botnar RM; Gawaz M; Bigalke B
    Clin Sci (Lond); 2012 Nov; 123(10):601-10. PubMed ID: 22690794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of uric acid in patients with acute coronary syndromes.
    Ndrepepa G; Braun S; Haase HU; Schulz S; Ranftl S; Hadamitzky M; Mehilli J; Schömig A; Kastrati A
    Am J Cardiol; 2012 May; 109(9):1260-5. PubMed ID: 22325088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.
    Waldo SW; Secemsky EA; O'Brien C; Kennedy KF; Pomerantsev E; Sundt TM; McNulty EJ; Scirica BM; Yeh RW
    Circulation; 2014 Dec; 130(25):2295-301. PubMed ID: 25391519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography.
    Ostrom MP; Gopal A; Ahmadi N; Nasir K; Yang E; Kakadiaris I; Flores F; Mao SS; Budoff MJ
    J Am Coll Cardiol; 2008 Oct; 52(16):1335-43. PubMed ID: 18929245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
    Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, atherosclerotic burden and cardiovascular prognosis.
    Espinola-Klein C; Rupprecht HJ; Bickel C; Lackner K; Schnabel R; Munzel T; Blankenberg S;
    Atherosclerosis; 2007 Dec; 195(2):e126-34. PubMed ID: 17336309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of sigma shaped right coronary artery is an indicator of poor prognosis in patients with inferior myocardial infarction treated with primary percutaneous coronary intervention.
    Güngör B; Alper AT; Ozcan KS; Ekmekçi A; Karadeniz FÖ; Mutluer FO; Kaya A; Karataş B; Osmonov D; Bolca O
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):965-72. PubMed ID: 24402881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries.
    Hartmann M; von Birgelen C; Mintz GS; Stoel MG; Eggebrecht H; Wieneke H; Fahy M; Neumann T; van der Palen J; Louwerenburg HW; Verhorst PM; Erbel R
    J Am Coll Cardiol; 2006 Aug; 48(3):446-52. PubMed ID: 16875967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkaline phosphatase and prognosis in patients with coronary artery disease.
    Ndrepepa G; Xhepa E; Braun S; Cassese S; Fusaro M; Schunkert H; Kastrati A
    Eur J Clin Invest; 2017 May; 47(5):378-387. PubMed ID: 28369867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.